
Achieve Life Sciences, Inc.
ACHVHealthcare|Biotechnology|US
$6.72
+0.34 (+5.41%)
DCF Value
$0.12
Cash / Share
$2.00
Ownership Breakdown
72.6%
Float
102.9M
Shares Outstanding
74.7M
Float Shares
Major Holders (40)
Combined: 272.9%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Jon Winkelried | Individual | 12.60% | 13,755,160 | Apr 24, 2026 | 13D/G |
| James G. Coulter | Individual | 12.60% | 13,755,160 | Apr 24, 2026 | 13D/G |
| TPG GP A, LLC | Other | 12.60% | 13,755,160 | Apr 24, 2026 | 13D/G |
| Logos Global Management GP LLC | HC, OO | 9.99% | 10,538,440 | Aug 17, 2026 | 13D/G |
| Arsani William | HC, IN | 9.99% | 10,538,440 | Aug 17, 2026 | 13D/G |
| Logos Global Management LP | IA, PN | 9.99% | 10,538,440 | Aug 17, 2026 | 13D/G |
| venBio Global Strategic Fund V, L.P. | Partnership | 9.99% | 10,737,317 | Apr 27, 2026 | 13D/G |
| venBio Global Strategic GP V, LLC | HC, OO | 9.99% | 10,737,317 | Apr 27, 2026 | 13D/G |
| Senai Asefaw, M.D. | Individual | 9.20% | 9,903,712 | Apr 24, 2026 | 13D/G |
| Paradigm BioCapital Advisors GP LLC | Other | 9.20% | 9,903,712 | Apr 24, 2026 | 13D/G |
| Paradigm BioCapital Advisors LP | Partnership | 9.20% | 9,903,712 | Apr 24, 2026 | 13D/G |
| Franklin Resources, Inc. | HC, CO | 8.30% | 8,878,942 | Jul 28, 2026 | 13D/G |
| Franklin Advisers, Inc. | IA, CO | 8.30% | 8,878,942 | Jul 28, 2026 | 13D/G |
| Paradigm BioCapital International Fund Ltd. | Corporation | 8.10% | 8,687,536 | Apr 24, 2026 | 13D/G |
| FHMLSP, L.P. | Partnership | 6.50% | 6,625,788 | Apr 24, 2026 | 13D/G |
| FHMLSP, L.L.C. | Other | 6.50% | 6,625,788 | Apr 24, 2026 | 13D/G |
| Frazier Life Sciences Public Fund, L.P. | Partnership | 6.50% | 6,625,788 | Apr 24, 2026 | 13D/G |
| Anand Parekh | Individual | 5.60% | 2,982,722 | Nov 14, 2025 | 13D/G |
| Alyeska Investment Group, L.P. | Investment adviser | 5.60% | 2,982,722 | Nov 14, 2025 | 13D/G |
| Alyeska Fund GP, LLC | Other | 5.60% | 2,982,722 | Nov 14, 2025 | 13D/G |
| JANUS HENDERSON GROUP Ltd. | Holding company | 5.40% | 5,502,064 | Aug 13, 2026 | 13D/G |
| Bong Y. Koh | Individual | 5.20% | 5,502,064 | Apr 24, 2026 | 13D/G |
| Venrock Healthcare Capital Partners III, L.P. | Partnership | 5.20% | 5,502,064 | Apr 24, 2026 | 13D/G |
| VHCP Co-Investment Holdings III, LLC | Other | 5.20% | 5,502,064 | Apr 24, 2026 | 13D/G |
| Venrock Healthcare Capital Partners EG, L.P. | Partnership | 5.20% | 5,502,064 | Apr 24, 2026 | 13D/G |
| VHCP Management III, LLC | Other | 5.20% | 5,502,064 | Apr 24, 2026 | 13D/G |
| VHCP Management EG, LLC | Other | 5.20% | 5,502,064 | Apr 24, 2026 | 13D/G |
| Nimish Shah | Individual | 5.20% | 5,502,064 | Apr 24, 2026 | 13D/G |
| Logos GP LLC | HC, OO | 5.10% | 5,200,000 | Aug 17, 2026 | 13D/G |
| Logos Global Master Fund LP | Partnership | 5.10% | 5,200,000 | Aug 17, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 5.10% | 5,271,391 | Jul 27, 2026 | 13D/G |
| Graham Walmsley | HC, IN | 5.00% | 5,338,440 | Aug 17, 2026 | 13D/G |
| Logos Opportunities V GP LLC | HC, OO | 5.00% | 5,338,440 | Aug 17, 2026 | 13D/G |
| Logos Opportunities Fund V LP | Partnership | 5.00% | 5,338,440 | Aug 17, 2026 | 13D/G |
| Vivo Opportunity, LLC | Other | 5.00% | 5,305,640 | Jul 8, 2026 | 13D/G |
| The Vanguard Group | Investment adviser | 4.95% | 1,717,014 | Apr 30, 2025 | 13D/G |
| Parker Quillen | Individual | 4.90% | 2,528,377 | Nov 14, 2025 | 13D/G |
| Contrarian Achieve SPV, LP | Partnership | 3.80% | 1,978,377 | Nov 14, 2025 | 13D/G |
| Contrarian Achieve GP LLC | Investment adviser | 3.80% | 1,978,377 | Nov 14, 2025 | 13D/G |
| Vivo Opportunity Co-Invest (Cycle 3), L.P. | Partnership | 2.00% | 2,140,852 | Jul 8, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 19,378,114 acquired · 20,626 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Halladay Benjamin | Chief Financial Officer | Oct 5, 2026 | AWARD | 200,000 | $7.01 | $1.4M | Form 4 |
| Halladay Benjamin | Chief Financial Officer | Oct 5, 2026 | AWARD | 200,000 | — | — | Form 4 |
| Halladay Benjamin | Oct 5, 2026 | OTHER | 0 | — | — | Form 4 | |
| Stewart Richard Alistair | director | Aug 19, 2026 | SELL | 20,626 | $8.49 | $175.2K | Form 4 |
| Sellig Thomas | director | Jul 27, 2026 | AWARD | 25,000 | $6.18 | $154.5K | Form 4 |
| Sellig Thomas | director | Jul 27, 2026 | AWARD | 16,700 | — | — | Form 4 |
| Martin Christopher Nathan | director | Jul 27, 2026 | AWARD | 25,000 | $6.18 | $154.5K | Form 4 |
| Martin Christopher Nathan | director | Jul 27, 2026 | AWARD | 16,700 | — | — | Form 4 |
| Royston Aaron | director | Jul 27, 2026 | AWARD | 25,000 | $6.18 | $154.5K | Form 4 |
| Royston Aaron | director | Jul 27, 2026 | AWARD | 16,700 | — | — | Form 4 |
| Waldman Reid Alexander | director | Jul 27, 2026 | AWARD | 25,000 | $6.18 | $154.5K | Form 4 |
| Waldman Reid Alexander | director | Jul 27, 2026 | AWARD | 16,700 | — | — | Form 4 |
| Stewart Richard Alistair | director | Jul 27, 2026 | AWARD | 25,000 | $6.18 | $154.5K | Form 4 |
| Stewart Richard Alistair | director | Jul 27, 2026 | AWARD | 16,700 | — | — | Form 4 |
| Farrow Jeffrey S | director | Jul 27, 2026 | AWARD | 25,000 | $6.18 | $154.5K | Form 4 |
| Farrow Jeffrey S | director | Jul 27, 2026 | AWARD | 16,700 | — | — | Form 4 |
| Phelan Nancy R. | director | Jul 27, 2026 | AWARD | 25,000 | $6.18 | $154.5K | Form 4 |
| Phelan Nancy R. | director | Jul 27, 2026 | AWARD | 16,700 | — | — | Form 4 |
| Waldman Reid Alexander | director | May 29, 2026 | AWARD | 47,250 | $5.24 | $247.6K | Form 4 |
| Farrow Jeffrey S | director | May 29, 2026 | AWARD | 47,250 | $5.24 | $247.6K | Form 4 |
| Waldman Reid Alexander | director | May 29, 2026 | OTHER | 0 | — | — | Form 4 |
| Farrow Jeffrey S | director | May 29, 2026 | OTHER | 0 | — | — | Form 4 |
| Martin Christopher Nathan | director | May 11, 2026 | AWARD | 47,250 | $5.59 | $264.1K | Form 4 |
| Martin Christopher Nathan | director | May 11, 2026 | OTHER | 0 | — | — | Form 4 |
| Royston Aaron | director | Apr 17, 2026 | OTHER | 0 | — | — | Form 4 |
| TPG GP A, LLC | 10 percent owner | Apr 17, 2026 | OTHER | 0 | — | — | Form 4 |
| TPG GP A, LLC | 10 percent owner | Apr 17, 2026 | OTHER | 6,877,580 | $3.51 | $24.1M | Form 4 |
| Iancovici Lucian | director | Apr 17, 2026 | OTHER | 0 | — | — | Form 4 |
| Goldberg Andrew D. | director, officer: CEO and President | Apr 18, 2026 | AWARD | 11,706,270 | — | — | Form 4 |
| Goldberg Andrew D. | director, officer: CEO and President | Apr 18, 2026 | AWARD | 3,601,929 | $4.25 | $15.3M | Form 4 |
| Goldberg Andrew D. | director, officer: CEO and President | Apr 18, 2026 | AWARD | 1,800,965 | — | — | Form 4 |
| Goldberg Andrew D. | director, officer: CEO and President | Apr 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Rubinstein Mark Lawrence | Chief Medical Officer | Jan 28, 2026 | AWARD | 180,000 | $4.36 | $784.8K | Form 4 |
| Oki Mark K | Chief Financial Officer | Jan 28, 2026 | AWARD | 180,000 | $4.36 | $784.8K | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Jan 28, 2026 | AWARD | 180,000 | $4.36 | $784.8K | Form 4 |
| Donnelly Craig | Chief Operations Officer | Jan 28, 2026 | AWARD | 180,000 | $4.36 | $784.8K | Form 4 |
| Stewart Richard Alistair | director, officer: Chief Executive Officer | Jan 28, 2026 | AWARD | 645,000 | $4.36 | $2.8M | Form 4 |
| Wan Jerry | Principal Accounting Officer | Jan 28, 2026 | AWARD | 70,300 | $4.36 | $306.5K | Form 4 |
| Rubinstein Mark Lawrence | Chief Medical Officer | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Rubinstein Mark Lawrence | Chief Medical Officer | Jan 1, 2026 | OTHER | 47,000 | $4.52 | $212.4K | Form 4 |
| Rubinstein Mark Lawrence | Chief Medical Officer | Jan 1, 2026 | OTHER | 50,000 | $3.10 | $155.0K | Form 4 |
| Atkisson Erik | Chief Legal Officer | Dec 4, 2025 | AWARD | 250,000 | $4.78 | $1.2M | Form 4 |
| Atkisson Erik | Chief Legal Officer | Oct 20, 2025 | OTHER | 0 | — | — | Form 4 |
| Donnelly Craig | Chief Operations Officer | Oct 1, 2025 | AWARD | 50,000 | $3.10 | $155.0K | Form 4 |
| Oki Mark K | Chief Financial Officer | Sep 18, 2025 | OPTION EX. | 168,000 | — | — | Form 4 |
| Oki Mark K | Chief Financial Officer | Sep 18, 2025 | SELL | 50,060 | $2.92 | $146.2K | Form 4 |
| Oki Mark K | Chief Financial Officer | Sep 18, 2025 | OPTION EX. | 168,000 | — | — | Form 4 |
| Stewart Richard Alistair | director, officer: Chief Executive Officer | Sep 18, 2025 | OPTION EX. | 297,500 | — | — | Form 4 |
| Stewart Richard Alistair | director, officer: Chief Executive Officer | Sep 18, 2025 | SELL | 129,501 | $2.92 | $378.1K | Form 4 |
| Stewart Richard Alistair | director, officer: Chief Executive Officer | Sep 18, 2025 | OPTION EX. | 157,500 | — | — | Form 4 |
| Donnelly Craig | Chief Operations Officer | Sep 8, 2025 | OTHER | 0 | — | — | Form 4 |
| Donnelly Craig | Chief Operations Officer | Sep 8, 2025 | OTHER | 22,500 | $4.55 | $102.4K | Form 4 |
| Donnelly Craig | Chief Operations Officer | Sep 8, 2025 | OTHER | 25,000 | $4.53 | $113.3K | Form 4 |
| Oki Mark K | Chief Financial Officer | Sep 4, 2025 | AWARD | 168,000 | — | — | Form 4 |
| Stewart Richard Alistair | director, officer: Chieve Executive Officer | Sep 4, 2025 | AWARD | 157,500 | — | — | Form 4 |
| Wan Jerry | Principal Accounting Officer | Sep 4, 2025 | OPTION EX. | 34,100 | — | — | Form 4 |
| Wan Jerry | Principal Accounting Officer | Sep 4, 2025 | OPTION EX. | 9,600 | — | — | Form 4 |
| Wan Jerry | Principal Accounting Officer | Sep 4, 2025 | SELL | 14,070 | $2.77 | $39.0K | Form 4 |
| Wan Jerry | Principal Accounting Officer | Sep 4, 2025 | OPTION EX. | 24,500 | — | — | Form 4 |
| KING THOMAS BRAXTON | director | Sep 4, 2025 | OPTION EX. | 455,000 | — | — | Form 4 |
| KING THOMAS BRAXTON | director | Sep 4, 2025 | SELL | 139,858 | $2.77 | $387.4K | Form 4 |
| KING THOMAS BRAXTON | director | Sep 4, 2025 | OPTION EX. | 455,000 | — | — | Form 4 |
| JACOBS CINDY | President & CMO | Sep 4, 2025 | OPTION EX. | 110,000 | — | — | Form 4 |
| JACOBS CINDY | President & CMO | Sep 4, 2025 | SELL | 27,629 | $2.77 | $76.5K | Form 4 |
| JACOBS CINDY | President & CMO | Sep 4, 2025 | OPTION EX. | 26,000 | — | — | Form 4 |
| JACOBS CINDY | President & CMO | Sep 4, 2025 | OPTION EX. | 84,000 | — | — | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Sep 4, 2025 | OPTION EX. | 69,000 | — | — | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Sep 4, 2025 | OPTION EX. | 20,000 | — | — | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Sep 4, 2025 | SELL | 20,854 | $2.77 | $57.8K | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Sep 4, 2025 | OPTION EX. | 49,000 | — | — | Form 4 |
| Slaoui Kristen B. | director | Jun 6, 2025 | AWARD | 31,500 | $3.83 | $120.6K | Form 4 |
| Phelan Nancy R. | director | Jun 6, 2025 | AWARD | 31,500 | $3.83 | $120.6K | Form 4 |
| Sellig Thomas | director | Jun 6, 2025 | AWARD | 31,500 | $3.83 | $120.6K | Form 4 |
| Martell Bridget A | director | Jun 6, 2025 | AWARD | 31,500 | $3.83 | $120.6K | Form 4 |
| KING THOMAS BRAXTON | director | Jun 6, 2025 | AWARD | 31,500 | $3.83 | $120.6K | Form 4 |
| Duty Stuart | director | Jun 6, 2025 | AWARD | 31,500 | $3.83 | $120.6K | Form 4 |
| Oki Mark K | Chief Financial Officer | Mar 17, 2025 | BUY | 10,000 | $2.89 | $28.9K | Form 4 |
| Stewart Richard Alistair | director, officer: Chieve Executive Officer | Mar 17, 2025 | BUY | 10,000 | $2.86 | $28.6K | Form 4 |
| Wan Jerry | Principal Accounting Officer | Jan 28, 2025 | AWARD | 48,000 | — | — | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Jan 28, 2025 | AWARD | 100,000 | — | — | Form 4 |
| JACOBS CINDY | director, officer: President & CMO | Jan 28, 2025 | AWARD | 130,000 | — | — | Form 4 |
| Slaoui Kristen B. | director | Jan 13, 2025 | AWARD | 47,250 | $3.32 | $156.9K | Form 4 |
| Phelan Nancy R. | director | Jan 13, 2025 | AWARD | 47,250 | $3.32 | $156.9K | Form 4 |
| Stewart Richard Alistair | director, officer: Chieve Executive Officer | Jan 13, 2025 | AWARD | 157,500 | — | — | Form 4 |
| Stewart Richard Alistair | director, officer: Chieve Executive Officer | Jan 13, 2025 | AWARD | 67,500 | $3.32 | $224.1K | Form 4 |
| KING THOMAS BRAXTON | director, officer: Executive Chairman | Jan 13, 2025 | AWARD | 455,000 | — | — | Form 4 |
| KING THOMAS BRAXTON | director, officer: Executive Chairman | Jan 13, 2025 | AWARD | 195,000 | $3.32 | $647.4K | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Jan 13, 2025 | AWARD | 20,000 | $3.32 | $66.4K | Form 4 |
| Slaoui Kristen B. | director | Jan 6, 2025 | OTHER | 0 | — | — | Form 4 |
| Phelan Nancy R. | director | Jan 6, 2025 | OTHER | 0 | — | — | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Dec 6, 2024 | AWARD | 30,000 | $4.52 | $135.6K | Form 4 |
| Oki Mark K | Chief Financial Officer | Dec 6, 2024 | AWARD | 168,000 | — | — | Form 4 |
| Oki Mark K | Chief Financial Officer | Dec 6, 2024 | AWARD | 72,000 | $4.52 | $325.4K | Form 4 |
| Oki Mark K | Chief Financial Officer | Dec 5, 2024 | OTHER | 0 | — | — | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Oct 15, 2024 | OTHER | 0 | — | — | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Oct 15, 2024 | OTHER | 1,000 | $67.40 | $67.4K | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Oct 15, 2024 | OTHER | 10,000 | $11.20 | $112.0K | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Oct 15, 2024 | OTHER | 22,500 | $8.26 | $185.8K | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Oct 15, 2024 | OTHER | 2,000 | $28.40 | $56.8K | Form 4 |
| Xinos Jaime | Chief Commercial Officer | Oct 15, 2024 | OTHER | 32,500 | $4.90 | $159.3K | Form 4 |